相似文献
1
Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia.
Emerg Infect Dis. 2003 Aug;9(8):1022-3. doi: 10.3201/eid0908.020373.
2
First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia.
Antimicrob Agents Chemother. 2006 Jan;50(1):226-9. doi: 10.1128/AAC.50.1.226-229.2006.
3
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Int J Antimicrob Agents. 2005 Jan;25(1):57-61. doi: 10.1016/j.ijantimicag.2004.08.013.
4
Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.
Diagn Microbiol Infect Dis. 2010 Jul;67(3):294-6. doi: 10.1016/j.diagmicrobio.2010.02.010. Epub 2010 May 11.
5
Metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in Brazil.
Clin Microbiol Infect. 2005 Nov;11(11):937. doi: 10.1111/j.1469-0691.2005.01249.x.
6
A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
J Antimicrob Chemother. 2007 Jul;60(1):132-5. doi: 10.1093/jac/dkm126. Epub 2007 May 4.
7
First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.
Antimicrob Agents Chemother. 2006 Jun;50(6):2272-3. doi: 10.1128/AAC.01440-05.
8
Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-beta-lactamase gene bla(VIM) in a level I Iranian burn hospital.
Burns. 2010 Sep;36(6):826-30. doi: 10.1016/j.burns.2009.10.011. Epub 2009 Dec 31.
9
Prevalence and molecular characterisation of metallo-beta-lactamase producing strains of imipenem-resistant Pseudomonas aeruginosa in Turkey.
Indian J Med Microbiol. 2014 Jul-Sep;32(3):349-50. doi: 10.4103/0255-0857.136622.
10
Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Chemotherapy. 2007;53(6):407-9. doi: 10.1159/000109815. Epub 2007 Oct 15.
引用本文的文献
1
Association of Biofilm Inducer with , , and in Isolates.
Arch Razi Inst. 2022 Oct 31;77(5):1723-1728. doi: 10.22092/ARI.2022.358104.2153. eCollection 2022 Oct.
2
Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae.
J Antibiot (Tokyo). 2017 Aug;70(9):974-978. doi: 10.1038/ja.2017.73. Epub 2017 Jul 5.
3
Antibiotic treatment at delivery shapes the initial oral microbiome in neonates.
Sci Rep. 2017 Feb 27;7:43481. doi: 10.1038/srep43481.
4
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.
Infect Chemother. 2015 Jun;47(2):81-97. doi: 10.3947/ic.2015.47.2.81. Epub 2015 Jun 30.
5
Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.
J Clin Microbiol. 2013 Feb;51(2):665-8. doi: 10.1128/JCM.03071-12. Epub 2012 Dec 12.
6
Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia.
Antimicrob Agents Chemother. 2012 May;56(5):2746-9. doi: 10.1128/AAC.05212-11. Epub 2012 Feb 27.
7
Complete Sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States.
Antimicrob Agents Chemother. 2008 Sep;52(9):3099-105. doi: 10.1128/AAC.01093-07. Epub 2008 Jun 30.
8
Carbapenemases: the versatile beta-lactamases.
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents. doi: 10.1128/CMR.00001-07.
9
Metallo-beta-lactamases: the quiet before the storm?
Clin Microbiol Rev. 2005 Apr;18(2):306-25. doi: 10.1128/CMR.18.2.306-325.2005.
10
Isolation of an integron-borne blaVIM-4 type metallo-beta-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary.
Antimicrob Agents Chemother. 2004 Sep;48(9):3576-8. doi: 10.1128/AAC.48.9.3576-3578.2004.
本文引用的文献
1
On functional and structural heterogeneity of VIM-type metallo-beta-lactamases.
J Antimicrob Chemother. 2003 Feb;51(2):257-66. doi: 10.1093/jac/dkg067.
2
Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2002 Dec;46(12):4026-8. doi: 10.1128/AAC.46.12.4026-4028.2002.
3
Emerging carbapenemases in Gram-negative aerobes.
Clin Microbiol Infect. 2002 Jun;8(6):321-31. doi: 10.1046/j.1469-0691.2002.00401.x.
4
Surveillance for antimicrobial resistance in Croatia.
Emerg Infect Dis. 2002 Jan;8(1):14-8. doi: 10.3201/eid0801.010143.
5
In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette.
Antimicrob Agents Chemother. 2001 Apr;45(4):1249-53. doi: 10.1128/AAC.45.4.1249-1253.2001.
6
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
Clin Infect Dis. 2000 Nov;31(5):1119-25. doi: 10.1086/317448. Epub 2000 Nov 6.
7
Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny.
Antimicrob Agents Chemother. 2000 May;44(5):1229-35. doi: 10.1128/AAC.44.5.1229-1235.2000.
8
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.
Antimicrob Agents Chemother. 1999 Jul;43(7):1584-90. doi: 10.1128/AAC.43.7.1584.
Zotero 插件